Predictive value of GRACE score combined with neutrophilic lymphocyte ratio on no-reflow phenomenon after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
-
摘要: 目的:探讨GRACE评分联合中性粒细胞/淋巴细胞(NLR)水平与急性ST段抬高型心肌梗死(STEMI)患者接受直接经皮冠状动脉介入(PCI)治疗后无复流现象的关系及预测价值。方法:对2018年10月1日—2019年12月31日就诊于河北省人民医院心脏中心行直接PCI治疗的急性STEMI患者269例进行回顾性分析。根据冠状动脉造影结果分为复流组(225例)和无复流组(44例)。应用二元Logistic回归分析确定无复流现象的独立预测因子,绘制ROC曲线以评估GRACE评分、NLR及两者联合对无复流现象的预测价值。结果:共纳入269例患者,无复流发生率为16.3%。调整混杂因素后,二元Logistic回归分析显示GRACE评分(OR=1.011,95%CI1.002~1.020,P=0.017),NLR(OR=1.068,95%CI1.008~1.132,P=0.025)是无复流发生的独立预测因子。在无复流预测中,GRACE评分在ROC曲线下面积0.621(95%CI0.553~0.709),敏感性为79.5%,特异性为44.2%,最佳临界值为118.5;NLR在ROC曲线下面积0.614(95%CI0.512~0.715),敏感性为91.1%,特异性为38.6%,临界值为10.97。GRACE评分联合NLR(联合预测因子)在ROC曲线下面积为0.641(95%CI0.550~0.732,P=0.03)。分别比较联合预测因子与单独GRACE评分和单独NLR的预测能力,均无统计学差异(P>0.05)。结论:GRACE评分、NLR均是无复流的独立预测因子,GRACE评分联合NLR可以预测STEMI患者PCI治疗后无复流现象的发生,但并未体现出优于单一使用GRACE评分或NLR的预测价值。
-
关键词:
- 无复流 /
- 急性ST段抬高型心肌梗死 /
- 经皮冠状动脉介入治疗 /
- GRACE评分 /
- 中性粒细胞/淋巴细胞
Abstract: Objective: To explore the relationship between GRACE score combined with the neutrophilic lymphocyte ratio(NLR) and no-reflow phenomenon after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction(STEMI).Methods: A retrospective analysis was performed on 269 patients with acute STEMI who received primary percutaneous coronary intervention. According to the results of angiography, they were divided into two groups: the reflow group(n=225) and no-reflow group(n=44). Binary Logistic regression analysis was used to identify the independent predictors of no-reflow, and ROC curves were performed to evaluate the predictive value of GRACE score, NLR and the combined factor.Results: A total of 269 patients were included, and the incidence of no-reflow was 16.3%. After adjusting for confounding factors, the results of binary logistic regression analysis showed that GRACE score(OR1.011, 95%CI: 1.002-1.020, P=0.017), NLR(OR1.068, 95%CI: 1.008-1.132, P=0.025) were independent predictors of no-reflow. In the predictive value of no-reflow, the area under ROC curve(AUC) of GRACE score was 6.21(95%CI: 0.553-0.709), its sensitivity was 79.5% and specificity was 44.2% and the best critical value was 118.5. The AUC of NLR was 6.14(95%CI: 0.512-0.715), its sensitivity was 91% and specificity was 38%, and the critical value was 10.97. The AUC of GRACE score combined with NLR was 6.41(95%CI0.55-0.732, P=0.03). There was no significant difference in predictive value among GRACE score combined with NLR, GRACE score alone and NLR alone(P>0.05).Conclusion: GRACE score and NLR are independent predictors of no-reflow. GRACE score combined with NLR is a better indicator to predict the no-reflow in STEMI patients after percutaneous coronary intervention, but is not superior to GRACE score or NLR alone. -
-
[1] 中华医学会心血管病分会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志,2019,47(10):1001-1010.
[2] 龚玥,赵素锐,李亚,等.伴2型糖尿病的急性心肌梗死经皮冠脉介入治疗术中无复流的因素分析及建议探讨[J].临床急诊杂志,2019,20(12):941-945.
[3] Vakili H,Shirazi M,Charkhkar M,et al.Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in m yocardial infarction frame count in ST-segment elevation myocardial infarction[J].Eur J Clin Invest,2017,47(4):322-327.
[4] Wang JW,Zhou ZQ,Chen YD,et al.A risk score for no reflow in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention[J].Clin Cardiol,2015,38(4):208-215.
[5] Wang Z,Ren L,Liu N,et al.Utility of Hematological Parameters in Predicting No-Reflow Phenomenon After Primary Percutaneous Cor onary Intervention in Patients With ST-Segment Elevation Myocardial Infarction[J].Clin Appl Thromb Hemost,2018,24(7):1177-1183.
[6] Sen N,Afsar B,Ozcan F,et al.The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention[J].Atherosclerosis,2013,228(1):203-210.
[7] Choi DH,Kobayashi Y,Nishi T,et al.Combination of mean platelet volume and neutrophil to lymphocyte ratio predicts long-term major adver se cardiovascular events after percutaneous coronary intervention[J].Angiology,2019,70(4):345-351.
[8] Lee MJ,Park SD,Kwon SW,et al.Relation between neutrophil-to-lymphocyte ratio and index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J].Am J Cardiol,2016,118(9):1323-1328.
[9] Alnasser SM,Huang W,Gore JM,et al.Late consequences of acute coronary syndromes:global registry of acute coronary events(GRACE)follow-up[J].Am J Med,2015,128(7):766-775.
[10] Granger CB,Goldberg RJ,Dabbous O,et al.Predictors of hospital mortality in the global registry of acute coronary events[J].Arch Intern Med,2003,163(19):2345-2353.
[11] Fox KA,Dabbous OH,Goldberg RJ,et al.Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome:prospective multinational observational study(GRACE)[J].BMJ,2006,333(7578):1091.
[12] 陈存芳,贾博,徐绍辉,等.经血栓抽吸导管注射重组人尿激酶原对高血栓负荷ST段抬高型心肌梗死患者急诊介入治疗效果的影响[J].临床心血管病杂志,2019,35(1):75-78.
[13] Wallentin L,Becker RC,Budaj A,et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes[J].N Engl J Med,2009,361(11):1045-1057.
[14] 杨汆,胡文志,王迪斌,等.STEMI患者PCI术前预注射尼可地尔对无复流的预防作用[J].临床心血管病杂志,2019,35(4):335-339.
[15] Mancini JG,Filion KB,Windle SB,et al.Meta-analysis of the long-term effect of routine aspiration thrombectomy in patients undergoing prima ry percutaneous coronary intervention[J].Am J Cardiol,2016,118(1):23-31.
[16] Rezkalla SH,Dharmashankar KC,Abdalrahman IB,et al.No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction:in cidence,outcome,and effect of pharmacologic therapy[J].J Interv Cardiol,2010,23(5):429-436.
[17] Shah VK,Shalia KK.Reperfusing the myocardium-a damocles Sword[J].Indian Heart J,2018,70(3):433-438.
[18] Blum A,Yeganeh S.The role of T-lymphocyte subpopulations in acute myocardial infarction[J].Eur J Intern Med,2003,14(7):407-410.
[19] 梁涛,杨诚,吴苏源,等.多项指标联合检测在细菌感染性疾病中的诊断价值[J].临床血液学杂志,2019,32(12):905-908,912.
[20] 高兵,黄铭,张辉,等.血细胞参数及比值在儿童甲型流感病毒感染中的应用价值[J].临床血液学杂志,2020,33(4):248-252.
[21] Wagdy S,Sobhy M,Loutfi M.Neutrophil/lymphocyte ratio as a predictor of in-hospital major adverse cardiac events,new-onset atrial fibrillation,and no-reflow phenomenon in patients with ST elevation myocardial infarction[J].Clin Med Insights Cardiol,2016,10:19-22.
[22] Zhang S,Diao J,Qi C,et al.Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention:a meta-analysis[J].BMC Cardiovasc Disord,2018,18(1):75.
[23] Akpek M,Kaya MG,Lam YY,et al.Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention[J].Am J Cardiol,2012,110(5):621-627.
[24] 华参,李田昌,田海涛,等.联合GRACE评分、TIMI-AF评分预测心房颤动并急性冠脉综合征介入治疗患者死亡风险[J].中国心血管病研究,2018,16(2):136-141.
[25] 胡昌灿,于海初,孙桂霞,等.PLR和NLR对非ST段抬高型急性冠状动脉综合征院内不良事件的预测[J].青岛大学学报(医学版),2019,55(4):485-491.
-
计量
- 文章访问数: 641
- PDF下载数: 248
- 施引文献: 0
下载: